— Know what they know.
Not Investment Advice

IDT.AX ASX

IDT Australia Limited
1W: -8.9% 1M: -10.9% 3M: +28.1% YTD: -8.9% 1Y: -36.9% 3Y: -28.7% 5Y: -92.9%
A$0.04 ($0.03)
-0.00 (-6.82%)
 
Weekly Expected Move ±9.2%
A$0 A$0 A$0 A$0 A$0
ASX · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 43 · A$17.5M mcap · 347M float · 0.062% daily turnover

Balance Sheet Trends

Total Assets
$35M -5.5% ▼
5Y CAGR: +0.4%
Total Liabilities
$16M +5.4% ▲
5Y CAGR: +19.5%
Shareholders Equity
$19M -13.0% ▼
5Y CAGR: -7.2%
Cash & Investments
$3M -38.7% ▼
5Y CAGR: -18.3%
Total Debt
$11M +4.0% ▲
5Y CAGR: +69.8%
Net Debt
$8M -16.1% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$9M$4M$504K$503K$3M
Short-Term Investments$0$0$400K$4M$0
Cash & ST Investments$9M$4M$904K$4M$3M
Net Receivables$2M$3M$7M$7M$6M
Inventory$1M$1M$2M$3M$3M
Other Current Assets$0$0$0$309K$100K
Total Current Assets$14M$10M$10M$16M$13M
Property, Plant & Equip.$16M$19M$21M$21M$22M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$87K
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$16M$19M$21M$21M$22M
Total Assets$30M$28M$31M$37M$35M
— Liabilities —
Accounts Payable$550K$346K$661K$747K$605K
Short-Term Debt$881K$740K$4M$816K$738K
Deferred Revenue$517K$829K$0$0$3M
Other Current Liabilities$703K$2M$766K$3M$915K
Total Current Liabilities$3M$4M$8M$5M$6M
Long-Term Debt$0$0$0$10M$10M
Other Non-Current Liab.$314K$166K$173K$159K$194K
Total Non-Current Liabilities$314K$166K$173K$10M$10M
Total Liabilities$3M$4M$8M$15M$16M
— Equity —
Common Stock$51M$55M$58M$64M$64M
Retained Earnings-$33M-$42M-$47M-$55M-$58M
Accumulated OCI$8M$11M$13M$13M$13M
Total Stockholders Equity$27M$24M$23M$22M$19M
Total Liabilities & Equity$30M$28M$31M$37M$35M
— Key Metrics —
Total Debt$881K$740K$4M$10M$11M
Net Debt-$8M-$4M$4M$10M$8M
Total Investments$0$0$400K$4M$87K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms